Procter & Gamble is facing several headwinds, which have weighed on its earnings and share price.
It doesn't expect an improvement in its next fiscal year.
The company has faced and overcome headwinds before.
When a 70-year dividend grower like Procter & Gamble (NYSE:PG) falls 18.5% from its all-time high, pushing its yield up to 3%, it's hard not to get intrigued. That seems like a real opportunity to buy shares of a high-quality company at a meaningful discount. However, it's important to question whether this decline is a gift or a warning.
I'm taking a deep dive into Procter & Gamble stock as I consider adding it to my portfolio. Here's why I'm beginning to conclude that while it's facing some real headwinds, the Dividend King -- a company with 50 or more years of annual dividend increases -- is starting to look like a real opportunity these days.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Image source: Getty Images.
Let's start with the negatives. Procter & Gamble's fiscal 2026 financial results weren't all that good. Its net sales rose 3% to $87 billion, while it delivered meager 1% organic sales growth. Likewise, its core earnings per share (EPS) were only up 1%. Meanwhile, it ended the year on a sour note, with organic sales flattening (though net sales rose 2%) while core EPS fell 3%. Its results fell short of its long-term growth algorithm, which calls for delivering organic sales growth ahead of the market and mid-to-high single-digit core EPS growth.
The company is facing several headwinds, including higher input costs and eroding market share. Persistently high inflation is causing more consumers to trade down to lower-cost, non-branded products. The biggest question is whether this shift is structural or cyclical.
Procter & Gamble expects its headwinds to persist in fiscal 2027. It sees higher raw materials, energy, and transportation costs, increased interest expenses, and unfavorable foreign exchange rates as having a $1 billion, or $0.56 per share, impact on its core EPS growth rate this year. That's an 8% drag on earnings growth. As a result, it expects core EPS to be flat to up 3%. Meanwhile, it sees organic sales growth of 1%-3% this year. Both below its long-term targets.
With its stock currently down about 18.5% from its all-time high, Procter & Gamble trades at around 22 times forward earnings. That's down from over 30 times earnings at its peak and from its historical average over the past decade in the upper 20s.
That's why its dividend yield is near its highest level in years. Procter & Gamble has increased its dividend for 70 years, including by 4% earlier this year. It has delivered a solid 4.8% compound annual dividend growth rate over the past decade.
Despite its sluggish earnings growth in recent years, Procter & Gamble still generates robust cash flow. It produced $19.6 billion in operating cash flow in its last fiscal year. The company returned over $15 billion to shareholders, paying $10.2 billion in dividends and repurchasing $5 billion of its shares.
While the company is currently facing growth and margin headwinds, it has experienced these speed bumps before, most recently in 2022 and 2023 when core EPS growth slowed to 3% and 2%, respectively. However, the company took action that paid off in 2024, when its core EPS surged 12%. The company is currently in the middle of a plan to streamline its portfolio, improve its cost structure, and invest in growth. It's also leveraging AI to develop new products tailored to specific consumer needs and to enhance its operations. The company believes this strategy will reaccelerate growth as its cost headwinds begin to fade.
Procter & Gamble is facing significant headwinds that will continue to slow its growth over the next fiscal year. However, the company has an action plan to reduce costs, streamline its portfolio, and invest in growth that could start delivering results later next year. That's why I believe the stock has become a real opportunity these days. At its currently discounted valuation and high yield, Procter & Gamble's downside from here appears low. Meanwhile, it has significant upside potential from accelerating earnings growth and an expansion in its valuation multiple if its strategy delivers results. This risk-reward profile has me seriously considering adding the Dividend King to my portfolio soon.
Before you buy stock in Procter & Gamble, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Procter & Gamble wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $365,910!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,418,530!*
Now, it’s worth noting Stock Advisor’s total average return is 930% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of October 3, 2026.
Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.